HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$157M |
| 2 |
Cognizant
CTSH
|
+$144M |
| 3 |
UnitedHealth
UNH
|
+$125M |
| 4 |
Apple
AAPL
|
+$124M |
| 5 |
Jackson Financial
JXN
|
+$124M |
Top Sells
| 1 |
Pinduoduo
PDD
|
+$255M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$207M |
| 3 |
NVIDIA
NVDA
|
+$173M |
| 4 |
Aramark
ARMK
|
+$170M |
| 5 |
Netflix
NFLX
|
+$155M |
Sector Composition
| 1 | Technology | 26.91% |
| 2 | Financials | 13.14% |
| 3 | Healthcare | 12.48% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Communication Services | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Atea Pharmaceuticals
AVIR
$258M
| $36K | ﹤0.01% |
+12,098
| New | +$36K |
|
|
TWOU
2127
DELISTED
2U, Inc.
TWOU
| $35.3K | ﹤0.01% |
+473
| New | +$35.3K |
|
|
TUYA
2128
Tuya Inc
TUYA
$1.57B
| $34.8K | ﹤0.01% |
22,476
+8,996
| +67% | +$13.9K |
|
2129
Kaltura
KLTR
$238M
| $34.8K | ﹤0.01% |
19,906
+63
| +0.3% | +$110 |
|
2130
Sangamo Therapeutics
SGMO
$158M
| $33.9K | ﹤0.01% |
56,544
| – | – |
|
|
TCS
2131
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $33.2K | ﹤0.01% |
994
| – | – |
|
2132
Angi Inc
ANGI
$819M
| $32.4K | ﹤0.01% |
1,616
| – | – |
|
2133
Aveanna Healthcare
AVAH
$1.73B
| $32.4K | ﹤0.01% |
26,978
| – | – |
|
2134
IAMGOLD
IAG
$5.8B
| $28K | ﹤0.01% |
+13,024
| New | +$28K |
|
|
OPTN
2135
DELISTED
OptiNose
OPTN
| $27.1K | ﹤0.01% |
1,449
| – | – |
|
2136
Nkarta
NKTX
$151M
| $27K | ﹤0.01% |
18,813
| – | – |
|
2137
SelectQuote
SLQT
$351M
| $26.9K | ﹤0.01% |
22,958
+10,774
| +88% | +$12.6K |
|
2138
Rigel Pharmaceuticals
RIGL
$742M
| $22.7K | ﹤0.01% |
2,110
+13
| +0.6% | +$140 |
|
2139
NextCure
NXTC
$13.2M
| $22.4K | ﹤0.01% |
1,447
| – | – |
|
|
OKYO
2140
OKYO Pharma
OKYO
$83.1M
| $22.1K | ﹤0.01% |
11,933
| – | – |
|
|
NGD
2141
New Gold Inc
NGD
$5.16B
| $21.5K | ﹤0.01% |
23,579
+7,370
| +45% | +$6.71K |
|
2142
Fossil Group
FOSL
$165M
| $21.4K | ﹤0.01% |
+10,432
| New | +$21.4K |
|
|
ADAP
2143
Adaptimmune Therapeutics
ADAP
$11.3M
| $20.1K | ﹤0.01% |
26,064
-107
| -0.4% | -$82 |
|
2144
Xeris Biopharma Holdings
XERS
$1.25B
| $19.8K | ﹤0.01% |
10,616
| – | – |
|
2145
Shattuck Labs
STTK
$90.1M
| $18.8K | ﹤0.01% |
12,501
| – | – |
|
2146
Q32 Bio
QTTB
$20.4M
| $17.7K | ﹤0.01% |
863
| – | – |
|
|
AGEN
2147
Agenus
AGEN
$136M
| $16.3K | ﹤0.01% |
735
| – | – |
|
2148
Gyre Therapeutics
GYRE
$717M
| $15.7K | ﹤0.01% |
2,169
| – | – |
|
|
NVTA
2149
DELISTED
Invitae Corporation
NVTA
| $14.6K | ﹤0.01% |
23,834
-3,010
| -11% | -$1.84K |
|
2150
ATAI Life Sciences
ATAI
$969M
| $14.4K | ﹤0.01% |
11,003
| – | – |
|